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“IS HORMESIS APPLICABLE AS A PRO-HEALTHY AGING INTERVENTION IN
MAMMALS AND HUMAN BEINGS, AND HOW?”
INTRODUCTION TO A SPECIAL ISSUE OF DOSE-RESPONSE
Éric Le Bourg   Centre de Recherche sur la Cognition Animale, UMR CNRS
5169, Université Paul-Sabatier, Toulouse, France
Suresh I.S. Rattan   Department of Molecular Biology, Aarhus University,
Aarhus, Denmark
The effects of a mild stress on aging are no longer terra incognita,
because in the last two decades several teams have published positive and
promising results on the matter (reviews in Le Bourg and Rattan 2008).
This is a far cry from the statement by Sacher (1977) that “hormesis is in
one sense an obstacle in the path of gerontological research”, because
hormetic effects “are unlikely to occur in the healthy active individual,
and are more likely to be significant in the ill or depressed animal”. We
have now gathered various experimental results, mainly in invertebrates,
showing favorable effects of mild stress on aging and also a few clinical
ones, but only a very few experimental studies have been done in mam-
mals. Results on human beings are promising and motivate a debate
among experts (the present issue) on the use of mild stress as a clinical
tool or in prevention of some effects of human aging. The purpose of this
introduction is not to summarize the articles of these invited experts but,
rather, to draw attention on some points of interest.
In 2006, the guest editors of the present issue arranged a debate in
Biogerontology (Vol.7, issue 3) to know whether experts were thinking
that dietary restriction could increase longevity in all species, and partic-
ularly in human beings. To our surprise, one half of the authors answered
“Yes” and the second half “No” (if we except an article concluding “Can’t
know”). We were therefore expecting that some authors would argue in
the present issue that mild stress could improve aging in experimental
animals, but definitely would not in human beings. It was not the case.
Obviously, all invited authors know that mild stress is efficient in human
beings in some occasions, e.g. in cardiology (see the article by Abete et al.
2010), and we did not expect that they would argue that these results can
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be discarded. Nevertheless, beyond these results in cardiology, no author
has argued that it is impossible to rely on hormesis to improve healthspan
in human beings. Therefore, all authors have provided the same answer
to the question “Is hormesis applicable as a pro-healthy aging interven-
tion in mammals and human beings?” and this answer is “Yes”. 
Most authors consider that answering to the second part of the ques-
tion (“and how?”) will not be an easy thing. The devil is in the details,
because using a mild stress in human beings is a source of many ethical
and practical questions. Most articles in the present issue have empha-
sized that a stress can be “mild” (favorable effects?) for a given individual
or “strong” (deleterious effects) for another one (see e.g. Rattan and
Demirovic 2010). In addition, a stress can be a mild one at one age and a
strong one later in life and we probably cannot perform the experiment
to know whether it were strong, for obvious ethical reasons. A mild stress
could also become a strong one if used in people already subjected to
another stress (see Sørensen et al. 2010). The basic questions are thus:
what mild stress could be used, when, with what dose?
Answering to the first question seems to be rather easy: exercise is
probably the best candidate (see e.g., Marques et al. 2010, Pardon 2010),
but heat stress is another one (e.g., Le Bourg 2010, Vaiserman 2010). It
has also been argued that chemicals (see Hayes 2010) could be a nutri-
tional stimulus with favorable effects. Yet, this is a short list of stresses and
the imagination of scientists is strongly required to discover new mild
stresses in human beings.
Answering to “When” using a mild stress will make sense probably
after a mild stress had been selected. Anyway, we should already try to
answer to the following question: should we apply the mild stress at a
young age, as in experimental models, or only at old age? It will be prob-
ably hard to convince young people to engage in a “mild stress” therapy
in the hope to improve their life when old. Elderly people would proba-
bly be more easily convinced, but would a mild stress still be efficient at
this age (Abete et al. 2010)?
Finally, the question “What dose?” is dependent on the answer to the
previous questions. Unfortunately, we will probably have to answer all
these questions at the same moment. Taking into account all these prob-
lems, Kahn and Olsen (2010) stress that “it is more likely that hormetic
therapy will become popular as treatment when used as an adjunct to
other treatment strategies for serious illnesses”, rather than in “normal
healthy individuals”. The other authors may probably consider this view
as a little pessimistic one.
Therefore, the road towards using mild stress in human beings is
probably more like a dirt track with many ruts than like a highway. It is
the hope of the guest editors that the present debate among experts will
provoke new studies on the use of hormesis in human beings.
É. Le Bourg and S. I. S. Rattan
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